Silex Systems (SLX) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
3 Feb, 2026Opening remarks and agenda
AGM opened with confirmation of quorum and welcome to both in-person and virtual attendees.
CEO/Managing Director Dr. Michael Goldsworthy led the meeting, focusing on technology commercialisation and strategic progress.
Board members, CEO, and auditor introduced; agenda included business update, financial review, and voting.
Shareholders provided with instructions for participation, voting, and Q&A.
Financial performance review
Market capitalisation reached approximately AUD 2 billion as of October 2025, with a share price of AUD 7.47 and about 277 million shares on issue.
Cash and term deposits stood at AUD 210 million as of 30 September 2025, with no corporate-level debt.
Balance sheet strengthened by AUD 150 million equity placement and nearly AUD 20 million share purchase plan, ensuring funding through FY 2028.
Institutional shareholders accounted for about 35% of the register.
Board and executive committee updates
Board composition highlighted, including the addition of a Non-Executive Director with global mining and finance experience.
Chris Wilks stood for reelection with full board support.
The Board authorised the release of the AGM presentation, highlighting ongoing risk management and forward-looking strategies.
Leadership praised for navigating a complex, regulated, and international business environment.
Latest events from Silex Systems
- GLE's SILEX technology targets US nuclear fuel independence with strong market and policy tailwinds.SLX
Investor presentation24 Feb 2026 - Revenue doubled and cash surged after a capital raise; GLE secured a major U.S. DOE award.SLX
H1 202624 Feb 2026 - Nuclear and quantum projects advanced, with strong cash reserves and key risks addressed.SLX
AGM 20243 Feb 2026 - Major technology milestone and US support position SILEX for uranium and quantum silicon growth.SLX
Investor Presentation9 Nov 2025 - Net loss widened to $42.6m as SILEX technology nears commercial readiness; strong cash raised.SLX
H2 202526 Aug 2025 - $145m equity raise funds SILEX laser enrichment commercialisation, targeting US nuclear fuel supply.SLX
Investor Presentation7 Aug 2025 - GLE's SILEX technology is on track for commercialisation, targeting major US nuclear fuel supply gaps.SLX
Investor Presentation30 Jun 2025 - GLE pilot and Silex's diversification position the company for growth amid nuclear market shifts.SLX
H2 202413 Jun 2025 - GLE accelerates SILEX technology for uranium, silicon, and isotope markets, targeting 2028 launch.SLX
Investor Presentation13 Jun 2025